Curanex Pharmaceuticals Common Stock

CURX | NASDAQ

$5.29

+$0.35 (+7.09%)

At close: Oct 30, 2026, 3:59 PM ET

$5.10

-$0.19 (-3.63%)

Pre-market: Nov 2, 2026, 4:00 AM ET

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023
Cash & Equivalents	4.97M	148.89K	74.37K
Short-Term Investments	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a
Receivables	n/a	n/a	n/a
Inventory	n/a	n/a	n/a
Other Current Assets	6.25M	367.87K	n/a
Total Current Assets	11.23M	517.94K	74.37K
Property-Plant & Equipment	352.62K	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a
Total Long-Term Assets	352.62K	n/a	n/a
Total Assets	11.58M	517.94K	74.37K
Account Payables	2.43K	5K	n/a
Deferred Revenue	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	-600
Total Current Liabilities	137.03K	14.58K	14.28K
Long-Term Debt	224.01K	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a
Total Long-Term Liabilities	224.01K	n/a	n/a
Total Liabilities	361.04K	14.58K	14.28K
Total Debt	346.7K	n/a	n/a
Book Value	11.22M	503.36K	60.09K
Book Value Per Share	7.92	0.36	0.04
Common Stock	2.83K	2.4K	60
Retained Earnings	-4.85M	-622.45K	-260.94K
Comprehensive Income	n/a	n/a	n/a
Shareholders Equity	11.22M	503.36K	60.09K
Total Investments	n/a	n/a	n/a